The Risk Assessment Team at Fox Chase Cancer Center
Mary B. Daly, MD, PhD, FACP
Chair, Department of Clinical Genetics
Timothy R. Talbot Jr. Chair for Cancer Research
A leader in cancer prevention and risk assessment at Fox Chase, Daly began one of the first risk assessment programs in the country in 1991 for people with a history of breast and/or ovarian cancer. Her primary areas of research include the epidemiologic and genetic aspects of breast and ovarian cancer, and the translation of this information into effective cancer prevention.
Michael J. Hall, MD
Director, Gastrointestinal, genitourinary, and endocrine risk assessment
Hall specializes in cancers of the gastrointestinal (GI) tract, with a specific interest in pancreas, small bowel, and colon tumors. Dr. Hall's recent research has focused on the risk of pancreatic cancer in BRCA 1/2 mutation carriers, risk communication, racial/ethnic disparities in genetic testing, and the costs and benefits of pharmacogenomics, or the study of how genes affect a person's response to drugs, and other genetic testing in the treatment of cancer.
Elias Obeid, MD, MPH
Attending Physician, Breast Cancer
Assistant Professor of Clinical Genetics and Medical Oncology
Director, Breast, ovarian, and prostate cancer risk assessment
Obeid is an expert in breast cancer, cancer risk assessment and prevention, hereditary cancer syndromes and medical ethics. He stresses the focus Fox Chase places on working as a team to individualize the care of every patient, as a member of the risk assessment program and the breast cancer service line.
Your genetic counselor will review your medical and family history in order to determine the personal and inherited factors that could affect your risk of developing cancer. They will help you understand the influence of these different risk factors and help to coordinate genetic testing, if appropriate.
Andrea Forman, MS, LCGC
Clinical Team Leader
Forman is a licensed and board-certified genetic counselor. As clinical team leader, Forman works as part of a multidisciplinary team to coordinate and provide expertise for clinical and research projects, solve clinical issues, and research novel ways of providing counseling interventions across a wide variety of hereditary cancer types and syndromes. Forman also teaches as an adjunct professor in Arcadia University’s Genetic Counseling master’s program, and works as a supervisor, counseling Arcadia genetic counseling students through their clinical rotation at Fox Chase.
Kim Rainey, MS, MEd, LCGC
Rainey is a licensed and board-certified genetic counselor who pursued a career in genetic counseling after working in secondary science education and in a clinical laboratory setting. Her focus is on empowering patients to make informed health care decisions for themselves and for their families, which is particularly important in the rapidly-changing fields of genetics and genomics.
Michelle Savage, MS, LCGC
Savage is a license and board-certified genetic counselor. She grew up in the Philadelphia area in Bucks County and began working in the Risk Assessment Program at Fox Chase in June 2014, after completing her master’s degree and several clinical internships at prominent medical centers in the region. In her multifaceted role at Fox Chase, Savage assesses candidates for genetic testing, explains the process so patients may make informed health decisions, and interprets testing results.
The Risk Assessment Program nurses perform a variety of roles in research and clinical care of high risks patients. The nurses provide cancer risk assessment, education and counseling. They help evaluate family and medical history and, if appropriate, help coordinate genetic testing. The nurses also see patients in our high risk clinics for medical management, cancer screening and risk reduction.
Agnes Masny, RN, MPH, MSN, CRNP
Masny is a certified registered nurse practitioner and research assistant with a depth of experience in cancer genetics. Since 1989, Masny supervises the clinical staff participating in research and genetic counseling in the Risk Assessment Program, and trains nurses in risk counseling. She runs two independent, high risk clinics, and reviews genetic test results with patients, helping them to plan for cancer surveillance and risk-reduction strategies. She is a member of many professional nursing societies, such as the American Nurses Association, Oncology Nursing Society, and the International Society for Nurses in Genetics.
Susan Montgomery, RN, BSN, OCN, GCN
Genetic Nurse Navigator
Montgomery has worked at Fox Chase for her entire nursing career. She joined the Risk Assessment Program 20 years ago at the advent of hereditary genetic testing. As a genetic nurse navigator, she assists the clinical genetics team in providing counseling and testing, as well as following high risk patients through their medical management and clinical follow-up.
Sharon Schwartz, CRNP, MSN, WHCNP
Schwartz is a certified registered nurse practitioner with a focus in women’s health. She has been a nurse practitioner in gynecologic oncology at Fox Chase since 2006. Schwartz splits her time between caring for patients in a survivorship setting in independent gynecologic oncology clinics, acting as the oncofertility coordinator for Fox Chase, and collaborating with genetics counselors during disclosure sessions in the Department of Clinical Genetics. She also sees women at high risk for breast and ovarian cancer in her high risk clinic, in collaboration with Dr. Daly.